Randomised recruitment calls impacted participant enrollment in longitudinal Alzheimer's disease studies, suggesting financial compensation may influence decisions.
INTRODUCTION: Recruitment and retention remains a major challenge in Alzheimer's disease research. This study examined the impact of describing potential financial compensation during recruitment on participant enrollment to a longitudinal cohort. METHODS: Participant recruitment calls (N = 337) were randomized to either a compensation-mentioned group (n = 170) or a control group (n = 167). An intention-to-treat logistic regression assessed the effect of compensation on enrollment. RESULTS: Of 320 analyzed, 124 (38.75%) enrolled. The intervention group's consent rate was lower than the control group's in intention-to-treat (-9.72 points; p = 0.074), per-protocol (-12.72 points; p = 0.026), and complier average causal effect analyses (-11.36 points; p = 0.72). DISCUSSION: Disclosing compensation during recruitment may reduce enrollment, potentially due to perceptions that compensation conflicts with altruistic motives. However, this was observed in a highly educated sample; compensation may affect those with lower levels of education and socioeconomic status differently by helping offset participation burden, warranting further investigation.
No takes yet. Share an insight, caveat, or question.
Gabel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: